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INTRODUCTION: This paper reports on an ongoing primary care audit of cancer referrals undertaken in Scotland in 2006–2007 and
2007–2008.
METHODS: General practitioners (GPs) in Scotland were asked to review all new cancer diagnoses within their practice during the
preceding year.
RESULTS: 4181 patients were identified in year 1 and 12294 in year 2. The pathway taken for patients to present to, and be referred
from, their GP has been analysed for 7430 of the 12294 patients identified within year 2 across five separate health boards. The time
from first symptoms to presentation to a GP varied between tumour types, being the longest (median 30 days) for head and neck
cancers and the shortest (median 2 days) for bladder cancer. In all, 25% of patients within the following tumour groups waited longer
than 2 months to present to their GP following first symptoms: prostate, colorectal, melanoma and head and neck cancers. Once
patients had presented to their GP, those with prostate and lung cancer were referred later (median time 11 days) than those with
breast cancer (median time 2 days). The priority with which GPs referred patients varied considerably between tumour groups
(breast cancer 77.5% ‘urgent’ compared with prostate cancer 44.7% ‘urgent’). In one health board the proportion of cancer patients
being referred urgently increased from 46% to 58% between the first and second audit.
CONCLUSION: Our data show that there are very different patterns of presentation and referral for patients with cancer, with some
tumour groups being more likely to be associated with a delayed diagnosis than others.
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Early presentation, prompt investigation and timely access to
definitive treatment unquestionably improves the experience of
patients, although there is some doubt about when and whether
delays affect outcomes with many cancers (Richards et al, 1999;
Jensen et al, 2007; Neal et al, 2007; Chen et al, 2008; Hamilton,
2009).
Different countries have different systems for allowing access to
specialist services. In the United Kingdom, other than diagnoses
made through the three screening services (breast, cervical and
more recently, colorectal cancers), patients usually first present to
their general practitioners (GPs). GPs have an important function
in assessing which patterns of symptoms are most likely to be
suggestive of cancer. If cancer is suspected, patients may be
referred immediately on first presentation for specialist assessment
and investigations, or they may have initial investigations and
review within primary care and then be referred when the results
of tests are available.
Specific guidelines have been developed in Scotland and
elsewhere to support GPs in referral decisions for patients with
suspected cancer (National Institute for Health and Clinical
Excellence, 2005; Scottish Executive Health Department (SEHD),
2007; Scottish Government, 2009).
Targets have been introduced in an attempt to ensure that
patients suspected of having cancer are seen and investigated
promptly, then fast-tracked for definitive treatment to cure or
palliate their cancer. In both England (Secretary of State for
Health, 1997) and Scotland (SEHD, 2001), there is a 62-day target
from referral to treatment for patients whose referral is marked
urgent and for those referred as an emergency (including self-
referral to accident and emergency departments). In England (but
not in Scotland), there is also a 2-week target from urgent referral
to first assessment by specialist services (Secretary of State for
Health, 1997).
The aim of this study is to gain a better understanding of how
quickly patients with cancer initially present to their GP, and how
they are then referred to secondary care for further investigation
and treatment.
MATERIALS AND METHODS
On two separate occasions between 2005 and 2008, GPs in most
health boards in Scotland were asked to review all new cancer
diagnoses within their practice during the preceding year. It was
hoped that by engaging practices in a cancer-review process, it
would be possible to consolidate knowledge around the early parts *Correspondence: Dr P Baughan; E-mail: paul.baughan@nhs.net
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symptom development and when and how to refer for further
investigation. The first audit took place in 2006–2007 and involved
reviewing all patients diagnosed with cancer in 2005–2006; the
second took place in 2007–2008, relating to patients diagnosed in
2006–2007. Engagement with the study was facilitated by the
enhanced service component of the General Medical Services
Contract, which enabled a payment for participating practices.
Participating GPs across Scotland were asked to review the
clinical notes of each new patient diagnosed with cancer and were
given guidance regarding how to record the items listed in Table 1
onto a standard electronic template. They were then asked to
reflect on the patient journey and to comment on ways that it
could have been improved. Patients with cancer detected through
the national screening programmes were excluded from the study,
as were those with non-melanoma skin cancer.
Data were available from five health boards across Scotland
during the first review, and from nine health boards during the
second (Scotland is served by 11 mainland and three island health
boards), and work is currently underway to amalgamate these data
across the whole of Scotland. The results in this paper relate to the
initial analysis of the second year’s data, taken from five of the nine
participating health boards. Comparative data from one health
board relating to priority of referral over the two separate years of
the audit have also been included.
RESULTS
In all, 4181 patients were identified with a new diagnosis of cancer
during year 1 and 12294 in year 2. This compares with a total of
B27000 new cases of cancer diagnosed each year in Scotland
(Information Services Division, 2008). In the first year of the audit,
each health board collected data in different ways, making
collation difficult. Arrangements in year 2 were more systematic,
allowing data to be collected on 12294 patients with cancer.
Detailed analysis has been conducted on data for 7430 of the 12294
patients. Data on the remaining 4864 patients are not yet analysed.
The 7430 cases analysed were identified by 540 GP practices from
five different health boards in Scotland. The cases covered all major
tumour types (Figure 1; Table 2) and reflected a similar pattern to
that reported nationally (Information Services Division, 2008).
This paper focuses on the analysis of the following:
(a) time from patient first noticing symptoms to first presentation
with a GP,
(b) time from first presentation to time of referral,
(c) priority of referral from primary to secondary care.
Time from patient first noticing symptoms to first
presentation with a GP
The time taken for patients to present to a GP varied according to
tumour site (Figure 2; Table 3). Patients with head and neck cancer
took the longest to present (median time 30 days). Patients with
melanoma (median time 26 days) and colorectal cancer (median
time 21 days) also presented comparatively late. In all, 25% of
patients with the following cancers waited longer than 1 month
before first presenting: breast, lung, lymphoma, ovarian and upper
gastrointestinal. For prostate, colorectal, melanoma, and head and
neck cancers, the same proportion of patients, 25%, waited 2
months or more to first present to a GP.
The shortest times between first noticing a sign or symptom and
first presentation to a GP were for patients with bladder cancer
(median time 2 days), leukaemia (4 days), cervical cancer (6.5
days) and breast cancer (7 days).
Table 1 Components of cancer diagnosis review
Patient diagnosis
Date patient first noticed symptoms
Date patient first reported symptoms to primary care
Date of decision to refer
Date referral sent
Priority given to referral (e.g. emergency, urgent, routine)
Use of any specific cancer referral pro forma
Method of sending referral (e.g. electronic, secure fax, post)
Date patient first seen by specialist
Date patient told the diagnosis
Date GP informed of diagnosis
Reflective comments on patient pathway through primary care
Abbreviation: GP¼general practitioner.
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Figure 1 Distribution of cancers within analysis.
Table 2 Distribution of cancers within analysis
Diagnosis group
Number of
referrals
Bladder 439
Breast 1250
Cervical 69
Colorectal 1074
Head and neck 273
Leukaemia 181
Lung 981
Lymphoma 260
Melanoma 353
Other 667
Other urological 258
Ovarian 152
Prostate 874
Upper GI 599
Abbreviation: GI¼gastrointestinal.
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Figure 2 Median time from first noticing symptoms to first presentation
with a GP.
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The time taken for a GP to refer a patient with a suspicion of
cancer also varied according to tumour group (Figure 3; Table 4).
Patients with breast cancer and melanoma were referred quickly
(median times 1 day and 2 days, respectively), whereas for other
tumour groups (notably lung and prostate), patients spent much
longer within the primary care part of the journey before being
referred to secondary care (lung cancer 11 days, prostate cancer
11 days). In all, 25% of patients with lung cancer and upper
gastrointestinal cancer were not referred for 1 month or more
following initial presentation.
Priority of referral from primary to secondary care
One of the most important factors determining time to diagnosis
was the priority with which the GP sent the referral. When the
referral priority was examined for the four most common
cancers (Figure 4; Table 5), a much higher proportion of
patients with breast cancer (969; 77.5%) and lung cancer (694;
70.7%) were referred ‘urgently’ to secondary care compared with
colorectal cancer (543; 50.6%) and prostate cancer (391; 44.7%).
Patients with colorectal and lung cancer were more likely than
prostate or breast cancer patients to present as an emergency
admission, and of these four tumour groups, patients with prostate
cancer had the highest likelihood of being referred to hospital
‘routinely’ (337; 38.6%). The category ‘other’ included referrals
that were marked as ‘soon’ and referrals to private hospitals or
clinics.
When referral priority data were compared within one of the
five health boards over the two separate time periods (following an
intensive GP education programme), the proportion of all cancers
presenting to GPs that were referred ‘urgently’ increased from 340
out of 739 referrals (46%) in 2005–2006 to 545 out of 940 referrals
(58%) in 2006–2007 (Figure 5). The difference in the total number
of cancers diagnosed from year 1 to year 2 is accounted for by a
slight increase in the number of GP practices taking part in the
audit during the second year.
The extent to which the priority of referral contributed to delays
in diagnosis was evident when the time to first see a hospital
Table 3 Median time from first noticing symptoms to first presentation
with a GP
Diagnosis group
Median
time (days)
Inter-quartile
range (days)
Bladder 2.0 14.0
Breast 7.0 30.0
Cervical 6.5 48.0
Colorectal 21.0 59.0
Head and neck 30.0 54.0
Leukaemia 4.0 23.0
Lung 9.5 31.0
Lymphoma 10.0 31.0
Melanoma 26.0 70.0
Other 15 58.0
Other urological 3.0 16.5
Ovarian 11.0 29.0
Prostate 14.0 61.0
Upper GI 14.0 43.0
Abbreviation: GI¼gastrointestinal.
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Figure 3 Median time from first presentation to time of referral.
Table 4 Median time from first presentation to time of referral
Diagnosis group
Median
time (days)
Inter-quartile
range (days)
Bladder 6.0 19.0
Breast 1.0 3.0
Cervical 5.0 22.0
Colorectal 4.5 21.0
Head and neck 4.0 14.0
Leukaemia 5.0 21.0
Lung 11.0 28.0
Lymphoma 6.0 22.0
Melanoma 2.0 6.0
Other 4.0 21.0
Other urological 4.0 23.0
Ovarian 4.0 15.5
Prostate 11.0 19.0
Upper GI 5.0 34.0
Abbreviation: GI¼gastrointestinal.
Breast
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Colorectal Lung Prostate
Diagnosis
%
 
o
f
 
r
e
f
e
r
r
a
l
s
 
s
e
n
t
 
a
s
Other Routine Urgent Emergency
Figure 4 Priority of referral by tumour group for breast, colorectal, lung
and prostate cancers.
Table 5 Priority of referral by tumour group for breast, colorectal, lung
and prostate cancers
% of referrals sent as priority
Diagnosis Emergency Urgent Routine Other
Breast 1.0 77.5 13.5 8.0
Colorectal 11.7 50.6 23.0 14.8
Lung 11.5 70.7 9.1 8.7
Prostate 3.8 44.7 38.6 12.9
Due to the effects of rounding, row totals may not equal 100% exactly.
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groups were examined, the time taken to see a specialist was
considerably longer if the patient was referred routinely (Figure 6;
Table 6). The median time for a patient with lung cancer to see a
specialist was 11 days for an urgent referral, yet 28 days for a
routine referral.
DISCUSSION
This study has yielded valuable information about the primary
care pathway for over 16000 patients diagnosed with cancer in
Scotland over two separate periods. Detailed analysis of 7430
patients from five separate health boards has been reported in this
paper. This has highlighted differences in the way that individual
cancers present to, and are referred by, GPs.
Patients with head and neck cancers, melanomas and colorectal
cancers waited comparatively longer before seeking help from
their GP. When the inter-quartile ranges were examined, it is
apparent that 25% patients with prostate cancer, colorectal cancer,
melanoma and head and neck cancers took longer than 2 months
to present to a GP following the first symptom or sign of cancer.
Limited research has been done on what causes patients to delay
presenting for advice or referral (Ramirez et al, 1999; Burgess
et al, 2001), but it is clear that many patients are not aware
of the common symptoms and signs that might suggest a diagnosis
of cancer. Although there have been occasional public education
and other campaigns to raise awareness and encourage early
presentation, there is little objective measurement of their
effectiveness. A recent study examined attempts to positively
influence and subsequently evaluate interventions to encourage
early presentation of women with breast cancer (Burgess et al,
2009).
GPs can influence the time from first presentation to referral.
The delay in referral for both lung and prostate cancer patients can
be explained by recommendations that initial assessments and
investigations be completed before referral (e.g. chest X-ray in
suspected lung cancer and evaluation of prostate-specific antigen
in prostate cancer) (SEHD, 2007).
For some tumour groups, less than half of all newly diagnosed
cancers were referred urgently. Of the four commonest tumour
groups, marked differences were noted between the proportions of
breast cancer patients referred urgently (969; 77.5%) compared
with colorectal (543; 50.6%) and prostate cancer patients
(391; 44.7%).
The importance of referring a patient with cancer ‘urgently’ is
that these patients are actively ‘fast-tracked’ through the hospital
diagnostic system to ensure compliance with the 62-day target
from urgent referral to treatment (SEHD, 2001). As ‘routine’ and
‘soon’ referrals are not subject to these targets, they are not
prioritised and invariably take much longer to start treatment
following the date of referral.
With this audit, GPs were given the opportunity to comment on
each individual patient’s pathway to diagnosis. On reflection, many
GPs indicated that they should have referred their patient more
urgently than they did; however, the most common explanation
from GPs was that the patient did not have the classic symptoms
and signs described within the urgent cancer referral guidelines.
Referral guidelines for some tumours may not always favour
patients with early symptoms of cancer. One study (Neal et al,
2007) found that for lung cancer (a tumour with a poor prognosis),
referral guidelines were prioritising those with more advanced
disease. However, the same was not found for patients with
colorectal, ovarian or prostate cancer.
Despite doubt about the benefit of urgent referral pathways, one
encouraging finding was the change in the proportion of patients
referred urgently within one health board during the two separate
years of the study. This change was also noted within several
different health boards and may reflect increasing awareness of
guidelines on the part of referrers and the increased priority that
cancer has been given in Scotland in recent years. Data are awaited
from a further audit (again through the enhanced service
component of the General Medical Services Contract) to examine
the compliance of all urgent suspected cancer referrals with
current referral guidelines.
By engaging with 540 different GP practices across five health
boards, there is a risk of variable data capture depending on the
thoroughness with which individual GPs reviewed their clinical
notes. The development of clear guidance for data collection and
the rigorous checking of all data submitted will have helped to
reduce this variability. However, by engaging with GPs across
Scotland in the collection of these data, it has been possible to
facilitate education around the typical presentation of cancer.
Comments written by GPs undertaking this audit provide a wealth
of information. Individual practices were frequently very open
about their shortcomings and appeared to provide perceptive
analysis of the diagnostic journey. Significant event analysis has
become an embedded part of reflective learning by GPs and forms
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Figure 5 Proportion of patients referred by priority group within one
health board over 2 successive years.
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Figure 6 Median time from referral sent to first seen by specialist.
Table 6 How referral priority influenced time to see specialist
Median time to see
specialist (days)
Diagnosis Routine Urgent
Breast 22.0 14.0
Colorectal 40.5 15.0
Lung 28.0 11.0
Prostate 32.0 17.0
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facilitated significant event analyses within many of the GP
practices taking part.
Although doubt has been cast on the benefit of cancer waiting
time targets, whether 2-week waits or 62-day targets (Jones et al,
2001), and some have shown a perverse adverse effect on breast
cancer referrals (Potter et al, 2007), public opinion and published
evidence supports the benefit of prompt recognition, prompt
referral and early effective treatment for patients with cancer.
Primary care health professionals have an important function in
early diagnosis.
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